HomeELAN • NYSE
add
Elanco Animal Health Inc
Previous close
$18.78
Day range
$18.22 - $18.82
Year range
$8.02 - $19.08
Market cap
9.21B USD
Avg Volume
9.40M
P/E ratio
21.26
Dividend yield
-
Primary exchange
NYSE
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 1.24B | 4.81% |
Operating expense | 628.00M | 9.41% |
Net income | 11.00M | 122.00% |
Net profit margin | 0.89 | 121.09% |
Earnings per share | 0.26 | -13.33% |
EBITDA | 246.00M | -7.87% |
Effective tax rate | 56.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 539.00M | 29.57% |
Total assets | 13.74B | -0.16% |
Total liabilities | 6.97B | -10.93% |
Total equity | 6.78B | — |
Shares outstanding | 496.81M | — |
Price to book | 1.38 | — |
Return on assets | 1.59% | — |
Return on capital | 1.96% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 11.00M | 122.00% |
Cash from operations | 237.00M | 18.50% |
Cash from investing | -56.00M | -69.70% |
Cash from financing | -156.00M | -67.74% |
Net change in cash | 52.00M | -26.76% |
Free cash flow | 119.12M | -48.71% |
About
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world. Wikipedia
Founded
1954
Website
Employees
9,225
